Michael Amoroso

Chief Executive Officer chez PRECISION BIOSCIENCES, INC.

Fortune : 735 212 $ au 31/03/2024

46 ans

Health Technology

Consumer Services

Postes actifs de Michael Amoroso

Sociétés	Poste	Début	Fin
ABEONA THERAPEUTICS INC.	Chairman	14/10/2021	-
	Director/Board Member	19/03/2021	14/10/2021
	Chief Executive Officer	19/03/2021	14/10/2021
	Chief Operating Officer	01/11/2020	19/03/2021
	Corporate Officer/Principal	09/07/2020	01/11/2020
	President	19/03/2021	14/10/2021
PRECISION BIOSCIENCES, INC.	Director/Board Member	15/10/2021	-
	Chief Executive Officer	15/10/2021	-
	President	15/10/2021	-

Sociétés	Poste	Début	Fin
KITE PHARMA INC	Corporate Officer/Principal	01/08/2018	01/01/2020

Rider University	Undergraduate Degree
The Leonard N Stern School of Business	Masters Business Admin

Internationale

Etats-Unis

Opérationnelle

Director/Board Member	2
Chief Executive Officer	2
Corporate Officer/Principal	2

Sectorielle

Health Technology	4
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
ABEONA THERAPEUTICS INC.	Health Technology
PRECISION BIOSCIENCES, INC.	Health Technology

Entreprise privées	1
Kite Pharma, Inc. Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA.	Health Technology

Entreprise privées

Health Technology